The first Adamis Pharmaceuticals trade was made in Q4 2016.
Since then Ken Griffin bought shares 26 more times and sold shares on 37 occasions. The investor completely sold their stake between Q2 2023 and Q2 2023.
Avg closing price
Price range
Sold -4.67 Thousand shares
Q2 2023
Avg closing price
$233.26
Price range
$1.90
-
$543.41
New holding (+4.67 Thousand shares)
Q1 2023
Avg closing price
$929.66
Price range
$495.88
-
$1,452.36
Sold -2.08 Thousand shares
Q4 2022
Avg closing price
$800.06
Price range
$616.42
-
$1,053.50
New holding (+2.08 Thousand shares)
Q3 2022
Avg closing price
$1,806.00
Price range
$972.65
-
$2,645.51
Sold -686 shares
Q2 2022
Avg closing price
$2,184.61
Price range
$1,674.82
-
$2,804.27
Sold 88.6% shares (-5.33 Thousand shares)
Q1 2022
Avg closing price
$3,004.46
Price range
$2,717.54
-
$3,577.00
Increased shares by 363.9% (+4.72 Thousand shares)
Q4 2021